Cargando…
Evaluation of Serum Ischemia Modified Albumin in Patients With COVID-19 Pneumonia: A Case-Control Study
Introduction: Various biomarkers are used when evaluating the hospitalization needs of patients diagnosed with Coronavirus disease (COVID-19). Ischemia-modified albumin (IMA) is a biomarker that causes blood levels to increase as a result of hypoxia and acidosis. We think that an increase in IMA in...
Autores principales: | Altintas, Emel, Sabirli, Ramazan, Yuksekkaya, Esra, Kurt, Ozgur, Koseler, Aylin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500556/ https://www.ncbi.nlm.nih.gov/pubmed/36168388 http://dx.doi.org/10.7759/cureus.28334 |
Ejemplares similares
-
Galectin-3 as a Potential Prognostic Biomarker for COVID-19 Disease: A Case-Control Study
por: Karsli, Emre, et al.
Publicado: (2022) -
Investigation of Serum Angiotensin-Converting Enzyme (ACE) Concentration and ACE Gene Polymorphism in Patients With SARS-CoV-2 Pneumonia Admitted to the Emergency Department
por: Goren, Tarik, et al.
Publicado: (2022) -
Soluble P-selectin as a potential diagnostic and prognostic biomarker for COVID-19 disease: A case-control study
por: Karsli, Emre, et al.
Publicado: (2021) -
High GRP78 levels in Covid-19 infection: A case-control study
por: Sabirli, Ramazan, et al.
Publicado: (2021) -
Preliminary Virtual Screening Studies to Identify GRP78 Inhibitors Which May Interfere with SARS-CoV-2 Infection
por: Palmeira, Andreia, et al.
Publicado: (2020)